Cite
MLA Citation
S. George et al.. “501 Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma who were treated beyond progression in a randomized phase 2 dose-ranging trial.” European journal of cancer, vol. 51, n.d., pp. S102–S103. http://access.bl.uk/ark:/81055/vdc_100030628020.0x000017